Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data
This study highlights the importance of long-term b/tsDMARD intervention in RA patients, with observed low mortality and high survival rates. Subgroup findings suggest the importance of comorbidity management in TNFi users and therapeutic stability in anti-IL6 users.
Authors
- T. Shivacheva (ORCID: https://orcid.org/0000-0001-7789-4100)
- Tsvetoslav Georgiev (ORCID: https://orcid.org/0000-0002-1652-4648)
- Zhaklin Apostolova
Institutions
- Medical University of Varna (BG)
- University Hospital St. Marina (BG)
Publication Details
- Journal
- Antibodies
- Published
- 2025-06-30
- DOI
- https://doi.org/10.3390/antib14030054
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67